Akihiro Tobe

ORCID: 0000-0001-6829-7611
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Imaging and Diagnostics
  • Coronary Interventions and Diagnostics
  • Cardiac Valve Diseases and Treatments
  • Cardiovascular Function and Risk Factors
  • Neuroscience and Neuropharmacology Research
  • Infective Endocarditis Diagnosis and Management
  • Cerebrovascular and Carotid Artery Diseases
  • Eicosanoids and Hypertension Pharmacology
  • Synthesis and biological activity
  • Acute Myocardial Infarction Research
  • Atrial Fibrillation Management and Outcomes
  • Receptor Mechanisms and Signaling
  • Olfactory and Sensory Function Studies
  • Cardiovascular Disease and Adiposity
  • Nicotinic Acetylcholine Receptors Study
  • Synthesis and Biological Evaluation
  • Synthesis and Reactivity of Heterocycles
  • Synthesis and Characterization of Heterocyclic Compounds
  • Neurotransmitter Receptor Influence on Behavior
  • Nitric Oxide and Endothelin Effects
  • Cardiac electrophysiology and arrhythmias
  • Circadian rhythm and melatonin
  • Pharmacological Effects of Natural Compounds
  • Cholinesterase and Neurodegenerative Diseases
  • Neuropeptides and Animal Physiology

Ollscoil na Gaillimhe – University of Galway
2023-2025

Nagoya University
2020-2023

Iwate Medical University
2023

Nagoya University Hospital
2020-2022

Tosei General Hospital
2016-2020

Mitsubishi Group (Japan)
1976-2004

Mitsubishi Chemical (Japan)
1981-1995

Osaka University
1989

Mitsubishi Chemical (Germany)
1983-1985

Andreas Baumbach Niels van Royen Ignacio J. Amat‐Santos Martin Hudec Matjaž Bunc and 95 more Alexander Ijsselmuiden Peep Laanmets Daniel Unić Béla Merkely Renicus S. Hermanides Vlasis Ninios Marcin Protasiewicz Benno J. Rensing Pedro Martín Fausto Feres Manuel Almeida Éric Van Belle Axel Linke Alfonso Ielasi Matteo Montorfano Mark Webster Konstantinos Toutouzas Emmanuel Teíger Francesco Bedogni Michiel Voskuil Manuel Pan Oskar Angerås Won‐Keun Kim Jürgen Rothe Ivica Kristić Vicente Peral Scot Garg Hesham Elzomor Akihiro Tobe Marie‐Claude Morice Yoshinobu Onuma Osama Soliman Patrick W. Serruys Dimytri Siqueira Ibraim Pinto Alberto Cervone Jorge Eduardo Assef Andréa Andrade Vilela A. Paladino Auristela Ramos Mariana T. Rezende Samira Kaissar Ghorayeb Tacianne Rolemberg Braga Silva Savica Gjorgjievska Irzal Hadžibegović Ivana Jurin Tomislav Šipić Nikola Pavlović Igor Rudež Šime Manola Romain Gallet Madjid Boukantar Eroan Nicolas Pierre Valdimir ENNEZAT Jean Marie Urien Flavien Vincent Cédric Delhaye Tom Denimal Alessandro Cosenza Thibault Pamart Sina Porouchani François Pontana David Montaigne Vincent Balmette Mohamed Yahya Bechiri Elisabeth Chen Dany Janah Matthias Renker Dirk Westermann Christian Valina Mirosław Ferenc Nikolaus Löffelhardt Faridun Rahimi Philipp Breitbart Kilian Franke Martin Czerny Nawras Diab Peter Sick Medea Adeishvili Norman Mangner Stephan Haußig Krunuslav Sveric Lisa Crusius Marie Roehlig Leonidas Koliastasis Maria Drakopoulou Odysseas Katsaros Nikolaos Ktenopoulos Andreas Ioanniadis Sotirios Evangelou Ilias Ninios Levente Molnár Roland Papp Ferencz Arnold-Béla Orsolya Kiss

10.1016/s0140-6736(24)00821-3 article EN The Lancet 2024-05-22

Diffuse coronary artery disease (CAD) impacts the immediate hemodynamic and clinical outcomes of percutaneous intervention (PCI). We evaluated whether diffuse pattern CAD derived from angiographic Quantitative flow ratio (QFR) outcome post-PCI medium term predicted vessel-oriented composite endpoint (VOCE). Paired pre-procedure QFRs were assessed in 503 patients 1022 vessels Multivessel TALENT (MVT) trial. The pathophysiological was defined as "predominantly diffuse" or "focal" according to...

10.1038/s41598-025-85872-9 article EN cc-by-nc-nd Scientific Reports 2025-01-17

The present study characterizes the neurochemical profile of newly synthesized compound 5-{3-[((2S)-l,4-benzodioxan-2-ylmethyl)amino]propoxy}-l,3-benzodioxole HC1 (MKC-242). In in vitro experiments, MKC-242 had high affinity for serotonin1A (5-HT1A) receptors (Ki: 0.35 nM) and moderate α1-adrenoceptors 21 nM), whereas it no appreciable any other neurotransmitter recognition sites studied 5-HT transporter. (0.3-3.0mg/kg, s.c.; 1-l0 mg/kg, p.o.) caused presynaptic 5-HT1A-receptor-mediated...

10.1254/jjp.69.357 article EN The Japanese Journal of Pharmacology 1995-01-01

Effects of bifemelane hydrochloride (MCI-2016) on acetylcholine (ACh) level in the cerebral cortex and hippocampus rats Mongolian gerbils were examined. In normal rats, MCI-2016 (30 mg/kg, i.p.) slightly increased ACh content cortex. Scopolamine (1 or hypoxia (95% N2 + 5% O2, 9 min) decreased pretreatment attenuated decrement rats. brain was significantly following ligation bilateral carotid arteries. this case, MCI-201 6 also level. These results suggest that improvement by behavioral...

10.1254/jjp.38.375 article EN The Japanese Journal of Pharmacology 1985-01-01

Dabigatran is a direct thrombin inhibitor used to decrease the risk of ischemic stroke in patients with non-valvular atrial fibrillation (NVAF). Its prodrug, dabigatran etexilate (DE) often co-administrated proton pump (PPI) because its adverse effects on gastrointestinal tract. Drug-drug interactions between DE and PPIs daily clinical practice have not been fully elucidated.Changes blood concentration (DC) were investigated using dilute time test randomized, open-label, two-period crossover...

10.1016/j.joa.2017.07.013 article EN cc-by-nc-nd Journal of Arrhythmia 2017-10-12

Abstract Murray law-based quantitative flow ratio (µQFR) assesses fractional reserve (FFR) in bifurcation lesions using a single angiographic view, enhancing the feasibility of analysis; however, accuracy may be compromised suboptimal projections. FFR CT is well-validated non-invasive method measuring from coronary computed tomographic angiography (CCTA). We evaluated µQFR left main (LM) bifurcations, impact optimal/suboptimal fluoroscopic view with respect to CCTA, and its diagnostic...

10.1007/s10554-023-02974-z article EN cc-by The International Journal of Cardiovascular Imaging 2023-10-23
Coming Soon ...